Cell Therapy Catapult\'s new UK facilities scheduled for Q1 2014 opening
Work is progressing on new office and lab space at Guy\'s Hospital, London
The Cell Therapy Catapult, a UK centre for excellence for regenerative medicine established in 2012, has announced that the fit-out of its £7.5m state-of-the-art new facilities at Guy's Hospital, London, is well underway.
Working with Guy’s and St Thomas’ NHS Foundation Trust on the refurbishment of the 12th floor of Guy's Tower Wing, the Cell Therapy Catapult expects the 1,200m2 of office and laboratory space will be operational by January 2014.
The new facilities will contain GMP-proving laboratories providing an intermediate step between early stage research and large-scale production for clinical trial and commercial supply. The latest equipment is being installed, enabling the development of scaled-up processes to grow, prepare and test cells for delivery to patients.
The adjoining office and networking space will comprise meeting rooms, open plan/hot desking and videoconferencing facilities, as well as a café.
We are planning a high-profile launch at the beginning of 2014, showing the expertise and technology we are installing
In addition, there will be a viewing area connecting the laboratories and offices, encouraging interaction between researchers and visits.
Keith Thompson, CEO of the Cell Therapy Catapult, said: ‘The Cell Therapy Catapult is committed to making our new premises an inspiring place to work, facilitating innovative research and collaboration. We are planning a high-profile launch at the beginning of 2014, showing the expertise and technology we are installing.’
The facility concept and outline layout was prepared by eXmoor pharma concepts, and working with Guy's and St Thomas' NHS Foundation Trust and Essentia, the Trust’s provider of integrated healthcare solutions, the project is being managed by Gleeds Management Services with refurbishment and fit-out by ISG.
The Cell Therapy Catapult currently occupies temporary office and laboratory space within the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London.